Ads
related to: alnylam pharmaceuticals- See How AMVUTTRA Works
View a diagram that explains
how AMVUTTRA works.
- How AMVUTTRA Was Studied
See how safety and efficacy
were evaluated in the study.
- View Dosing Information
AMVUTTRA is given
by an HCP.
- Study Results
See the results of the clinical
study for AMVUTTRA.
- Treatment Process
Watch the treatment process video
for AMVUTTRA.
- Find a Treatment Center
Locate the treatment center
closest to you.
- See How AMVUTTRA Works
Search results
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q4 2023 Earnings Call Transcript February 15, 2024...
Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Profit Outlook
Simply Wall St. via Yahoo Finance· 10 months agoAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is possibly approaching a major achievement in its...
The Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) First-Quarter Results Are Out And Analysts Have...
Simply Wall St. via Yahoo Finance· 2 weeks agoAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) just released its latest first-quarter results and...
Investors in Alnylam Pharmaceuticals (NASDAQ:ALNY) have seen strong returns of 121% over the past...
Simply Wall St. via Yahoo Finance· 7 months agoAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shareholders might be concerned after seeing the share...
Alnylam Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 3 weeks agoAlnylam Pharmaceuticals (NASDAQ:ALNY) First Quarter 2024 Results Key Financial Results Revenue:...
Should You Buy Alnylam Pharmaceuticals (ALNY) Ahead of Earnings?
Zacks via Yahoo Finance· 1 year agoAlnylam Pharmaceuticals (ALNY) is seeing favorable earnings estimate revision activity and has a...
Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 3 weeks agoAlnylam Pharmaceuticals Inc (NASDAQ:ALNY) showcases robust revenue growth with a 54.8% increase in...
Is There An Opportunity With Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) 44% Undervaluation?
Simply Wall St. via Yahoo Finance· 1 year agoHow far off is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) from its intrinsic value? Using the most...
Those who invested in Alnylam Pharmaceuticals (NASDAQ:ALNY) five years ago are up 94%
Simply Wall St. via Yahoo Finance· 2 years agoAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shareholders have seen the share price descend 22% over...
Alnylam (ALNY) Q1 Earnings Beat, Product Sales Drive Revenues
Zacks via Yahoo Finance· 1 year agoAlnylam Pharmaceuticals (ALNY) reports better-than-expected first-quarter 2023 results. Givlaari,...
Ads
related to: alnylam pharmaceuticals